ArticleJournal of Alzheimer's disease : JAD2026

Leading by example: How the Webster team's systematic review quietly rebuked the field's preoccupation with biomarker "disclosure," and why it matters.

Jennifer H LinglerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.